⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
Class Action Reminder from Pomerantz LLP for Shareholders of Alarum Technologies Ltd. – ALAR
accessnewswire.com
ALAR
Pomerantz LLP Updates Shareholders on Legal Action Brought Against TruGolf Holdings, Inc. – TRUG
accessnewswire.com
TRUG
Pomerantz LLP Notifies Investors of Class Action Lawsuit Against Blaize Holdings, Inc. – BZAI
accessnewswire.com
BZAI
Single infusion of CARVYKTI® (ciltacabtagene autoleucel) delivered five-year treatment-free remissions in 50% of patients in early line relapsed/refractory multiple myeloma
prnewswire.com
JNJ
Pomerantz LLP Updates Investors on Legal Action Brought Against Alibaba Group Holding Limited – BABA
accessnewswire.com
BZAI
BABA
Class Action Litigation Filed by Pomerantz LLP Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Pomerantz LLP Updates Shareholders on Legal Action Brought Against Rackspace Technology, Inc. – RXT
accessnewswire.com
RXT
Pomerantz LLP Updates Shareholders on Legal Action Brought Against Capricor Therapeutics, Inc. – CAPR
accessnewswire.com
CAPR
Class Action Lawsuit Reminder from Pomerantz LLP for Investors of iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) – ITOC
accessnewswire.com
ITOC
Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin granted Priority Review in the US for patients with muscle-invasive bladder cancer
businesswire.com
AZN